• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-18的结构与结合模式。

The structure and binding mode of interleukin-18.

作者信息

Kato Zenichiro, Jee JunGoo, Shikano Hiroaki, Mishima Masaki, Ohki Izuru, Ohnishi Hidenori, Li Ailian, Hashimoto Kazuyuki, Matsukuma Eiji, Omoya Kentaro, Yamamoto Yutaka, Yoneda Teruyo, Hara Takane, Kondo Naomi, Shirakawa Masahiro

机构信息

Department of Pediatrics, Gifu University School of Medicine, Tsukasa 40, Gifu 500-8705, Japan.

出版信息

Nat Struct Biol. 2003 Nov;10(11):966-71. doi: 10.1038/nsb993. Epub 2003 Oct 5.

DOI:10.1038/nsb993
PMID:14528293
Abstract

Interleukin-18 (IL-18), a cytokine formerly known as interferon-gamma- (IFN-gamma-) inducing factor, has pleiotropic immunoregulatory functions, including augmentation of IFN-gamma production, Fas-mediated cytotoxicity and developmental regulation of T-lymphocyte helper type I. We determined the solution structure of IL-18 as a first step toward understanding its receptor activation mechanism. It folds into a beta-trefoil structure that resembles that of IL-1. Extensive mutagenesis revealed the presence of three sites that are important for receptor activation: two serve as binding sites for IL-18 receptor alpha (IL-18Ralpha), located at positions similar to those of IL-1 for IL-1 receptor type I (IL-1RI), whereas the third site may be involved in IL-18 receptor beta (IL-18Rbeta) binding. The structure and mutagenesis data provide a basis for understanding the IL-18-induced heterodimerization of receptor subunits, which is necessary for receptor activation.

摘要

白细胞介素-18(IL-18),一种以前被称为γ-干扰素(IFN-γ)诱导因子的细胞因子,具有多效性免疫调节功能,包括增强IFN-γ的产生、Fas介导的细胞毒性以及I型辅助性T淋巴细胞的发育调节。我们确定了IL-18的溶液结构,作为理解其受体激活机制的第一步。它折叠成一个类似于IL-1的β-三叶结构。广泛的诱变揭示了三个对受体激活很重要的位点:两个作为IL-18受体α(IL-18Rα)的结合位点,其位置与IL-1对I型IL-1受体(IL-1RI)的位置相似,而第三个位点可能参与IL-18受体β(IL-18Rβ)的结合。结构和诱变数据为理解IL-18诱导的受体亚基异二聚化提供了基础,这是受体激活所必需的。

相似文献

1
The structure and binding mode of interleukin-18.白细胞介素-18的结构与结合模式。
Nat Struct Biol. 2003 Nov;10(11):966-71. doi: 10.1038/nsb993. Epub 2003 Oct 5.
2
Interleukin-18.白细胞介素-18
Methods. 1999 Sep;19(1):121-32. doi: 10.1006/meth.1999.0837.
3
[Interleukin-18].[白细胞介素-18]
Postepy Hig Med Dosw. 2003;57(6):685-99.
4
Expression of interleukin 12 receptor (IL-12R) and IL-18R on CD4+ T cells from patients with rheumatoid arthritis.类风湿关节炎患者CD4 + T细胞白细胞介素12受体(IL - 12R)和白细胞介素18受体(IL - 18R)的表达
J Rheumatol. 2004 Mar;31(3):448-56.
5
Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.白细胞介素18的免疫调节功能及其在抵御细菌病原体中的作用。
J Mol Med (Berl). 2002 Mar;80(3):147-62. doi: 10.1007/s00109-001-0307-1. Epub 2001 Dec 8.
6
Generation of highly stable IL-18 based on a ligand-receptor complex structure.基于配体-受体复合物结构生成高度稳定的白细胞介素-18。
Biochem Biophys Res Commun. 2004 Apr 23;317(1):181-6. doi: 10.1016/j.bbrc.2004.03.024.
7
[Biological properties of interleukin 18].[白细胞介素18的生物学特性]
Pol Merkur Lekarski. 2004 Mar;16(93):279-81.
8
Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.血管紧张素II增强白细胞介素-18介导的血管平滑肌细胞炎症基因表达:动脉粥样硬化发病机制中的一种新型相互作用。
Circ Res. 2005 May 27;96(10):1064-71. doi: 10.1161/01.RES.0000168210.10358.f4. Epub 2005 Apr 28.
9
Human anti-human IL-18 antibody recognizing the IL-18-binding site 3 with IL-18 signaling blocking activity.
J Biochem. 2005 Oct;138(4):433-42. doi: 10.1093/jb/mvi148.
10
IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.白细胞介素-23与白细胞介素-12不同,它对CD56+/CD3-自然杀伤细胞和CD56+/CD3+自然杀伤样T细胞功能的调节方式存在差异。
Int Immunol. 2009 Feb;21(2):145-53. doi: 10.1093/intimm/dxn132. Epub 2008 Dec 15.

引用本文的文献

1
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy.具有延长半衰期和更高稳定性的工程化白细胞介素-18变体用于癌症免疫治疗。
J Immunother Cancer. 2025 Jul 15;13(7):e011789. doi: 10.1136/jitc-2025-011789.
2
Role of Non-Binding T63 Alteration in IL-18 Binding.非结合性T63改变在白细胞介素-18结合中的作用。
Int J Mol Sci. 2024 Dec 3;25(23):12992. doi: 10.3390/ijms252312992.
3
Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome.白细胞介素-18经半胱天冬酶-4非经典炎性小体的识别与成熟
Nature. 2023 Dec;624(7991):442-450. doi: 10.1038/s41586-023-06742-w. Epub 2023 Nov 22.
4
A small non-interface surface epitope in human IL18 mediates the dynamics and self-assembly of IL18-IL18BP heterodimers.人白细胞介素18(IL18)中的一个小的非界面表面表位介导了IL18-IL18结合蛋白(IL18BP)异二聚体的动力学和自组装。
Comput Struct Biotechnol J. 2023 Jul 1;21:3522-3531. doi: 10.1016/j.csbj.2023.06.021. eCollection 2023.
5
Chicken adaptive response to nutrient density: immune function change revealed by transcriptomic analysis of spleen.鸡对营养密度的适应性反应:通过脾脏转录组分析揭示的免疫功能变化。
Front Immunol. 2023 May 15;14:1188940. doi: 10.3389/fimmu.2023.1188940. eCollection 2023.
6
The Role of the Interleukin-1 Family in Complications of Prematurity.白细胞介素-1 家族在早产儿并发症中的作用。
Int J Mol Sci. 2023 Feb 1;24(3):2795. doi: 10.3390/ijms24032795.
7
Interleukin-18 and IL-18BP in inflammatory dermatological diseases.白细胞介素-18 和白细胞介素-18BP 在炎症性皮肤病中的作用。
Front Immunol. 2023 Jan 18;14:955369. doi: 10.3389/fimmu.2023.955369. eCollection 2023.
8
Sublytic gasdermin-D pores captured in atomistic molecular simulations.原子分子模拟捕获的亚毒性 Gasdermin-D 孔。
Elife. 2022 Nov 14;11:e81432. doi: 10.7554/eLife.81432.
9
Altered Expression of Interleukin-18 System mRNA at the Level of Endometrial Myometrial Interface in Women with Adenomyosis.子宫腺肌病患者子宫内膜与肌层交界处白细胞介素-18系统mRNA的表达改变
Curr Issues Mol Biol. 2022 Nov 9;44(11):5550-5561. doi: 10.3390/cimb44110376.
10
Surface cysteine to serine substitutions in IL-18 reduce aggregation and enhance activity.IL-18 表面半胱氨酸到丝氨酸的取代减少了聚集并增强了活性。
PeerJ. 2022 Jul 5;10:e13626. doi: 10.7717/peerj.13626. eCollection 2022.